Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
12,811
Total Claims
$1.2M
Drug Cost
1,196
Beneficiaries
$967
Cost/Patient
Risk Score Breakdown 25/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-42%
Opioid rate vs peers
1.3% vs 2.2% avg
-31%
Cost per patient vs peers
$967 vs $1,411 avg
+48%
Brand preference vs peers
15.8% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
1.3%
Opioid Rate
166
Opioid Claims
$9,142
Opioid Cost
16.9%
Long-Acting Rate
Brand vs Generic
Brand: 2,009 claims · $898K
Generic: 10,720 claims · $253K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 248 | $121K |
| Tirzepatide | 45 | $87K |
| Dulaglutide | 74 | $83K |
| Empagliflozin | 71 | $44K |
| Rivaroxaban | 94 | $43K |
| Sitagliptin Phosphate | 29 | $39K |
| Insulin Glargine,hum.Rec.Anlog | 56 | $37K |
| Dapagliflozin Propanediol | 28 | $27K |
| Mirabegron | 31 | $22K |
| Semaglutide | 13 | $20K |
| Insulin Aspart | 30 | $18K |
| Insulin Detemir | 20 | $17K |
| Insulin Lispro | 20 | $17K |
| Fluticasone/Umeclidin/Vilanter | 14 | $14K |
| Budesonide/Formoterol Fumarate | 17 | $12K |
Prescribing Profile
Patient Profile
77
Avg Age
53%
Female
1.75
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About